EUVIMEDSkopri EUVIMED
Open access · CC BY-NC-ND 4.0

Clinical nodal staging to assess the risk of local recurrence after rectal cancer resection: A nationwide cross‐sectional study

Mirthe Ubink iD, Eline G M van Geffen, Tania C Sluckin, Sanne-Marije J A Hazen, Karin Horsthuis, Joost Nederend, Regina G H Beets-Tan, Martijn P W Intven, Cornelis Verhoef, Miranda Kusters iD, Pieter J Tanis iD, Dutch Snapshot Research Group

Colorectal Disease · 2025

DOI: 10.1111/codi.70257 ↗

At a glance

Journal article in Colorectal Disease, 2025. Written by Mirthe Ubink and 11 co-authors. Institution: Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Nether…. Major MEDLINE topics: Rectal Neoplasms, Neoplasm Recurrence, Local, Lymph Nodes. 27 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: KWF Kankerbestrijding.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Aim

In rectal cancer, neo‐adjuvant (chemo)radiotherapy (n(C)RT) should be used selectively, due to related toxicity. The decision to offer n(C)RT is mainly based on preoperative MRI staging. cN category has limited accuracy and its use when deciding on n(C)RT is controversial. This population‐based study aimed to assess the association between cN category and local recurrence (LR) rate.

Method

Data from a national cross‐sectional cohort of patients who underwent curative resection of primary rectal cancer in the Netherlands in 2016 were used. Patients were subdivided by neo‐adjuvant treatment strategy: no n(C)RT, short‐course RT with short interval to surgery (SCRT‐SI) or downstaging therapy (SCRT with long interval to surgery, CRT, total neoadjuvant therapy or chemotherapy only). The 4‐year LR rate was calculated per (y)cN category and corrected for known pre‐operative confounders in Cox‐regression analysis.

Results

Of 2148 included patients, 1000 received no n(C)RT, 449 SCRT‐SI and 699 downstaging therapy. Median follow‐up was 50 months (interquartile range [IQR] 38–55). The 4‐year LR rates for cN0, cN1 and cN2 were 6.3%, 5.0% and 6.2% without n(C)RT, and 0%, 2.4% and 0% after SCRT‐SI. In patients treated with downstaging therapy, not primary cN, but restaging ycN category was significantly associated with LR rate (9.1%, 17.4% and 18.5%; p = 0.006) in univariable analysis. In multivariable analysis, no association was observed between ycN and LR ( p = 0.088).

Conclusion

Evaluation of nationwide clinical practice did not reveal significant associations between cN category and LR rate after rectal cancer resection within three neo‐adjuvant treatment groups, which questions its validity for clinical decision‐making.

Subjects

MeSH terms (MEDLINE)

Rectal NeoplasmsNeoplasm Recurrence, LocalLymph NodesHumansCross-Sectional StudiesFemaleMaleMiddle AgedNeoplasm StagingAgedNetherlandsNeoadjuvant TherapyRisk AssessmentRisk FactorsProctectomyProportional Hazards ModelsChemoradiotherapy, Adjuvant

Author keywords

MRI stagingcN categorylocal recurrenceneoadjuvant therapyrectal cancer

Authors and institutions

  • Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Department of Medical Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Cancer Center Amsterdam, Treatment and Quality of Life and Imaging and Biomarkers, Amsterdam, The Netherlands.
  • Department of Radiology and Nuclear Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Department of Radiology, Catharina Hospital, Eindhoven, The Netherlands.

ORCID profiles: Mirthe Ubink, Miranda Kusters, Pieter J Tanis

Funding

  • KWF Kankerbestrijding

Cite

APA

Ubink, M., van Geffen, E. G. M., Sluckin, T. C., Hazen, S. J. A., Horsthuis, K., Nederend, J., Beets-Tan, R. G. H., Intven, M. P. W., Verhoef, C., Kusters, M., Tanis, P. J., & Dutch Snapshot Research Group (2025). Clinical nodal staging to assess the risk of local recurrence after rectal cancer resection: A nationwide cross‐sectional study. Colorectal Disease. https://doi.org/10.1111/codi.70257

Vancouver

Ubink M, van Geffen EGM, Sluckin TC, Hazen SJA, Horsthuis K, Nederend J, et al. Clinical nodal staging to assess the risk of local recurrence after rectal cancer resection: A nationwide cross‐sectional study. Colorectal Disease. 2025. doi:10.1111/codi.70257

BibTeX
@article{Ubink2025,
  author = {Ubink, Mirthe and van Geffen, Eline G M and Sluckin, Tania C and Hazen, Sanne-Marije J A and Horsthuis, Karin and Nederend, Joost and Beets-Tan, Regina G H and Intven, Martijn P W and Verhoef, Cornelis and Kusters, Miranda and Tanis, Pieter J and Dutch Snapshot Research Group, Dutch Snapshot Research Group},
  title = {Clinical nodal staging to assess the risk of local recurrence after rectal cancer resection: A nationwide cross‐sectional study},
  journal = {Colorectal Disease},
  year = {2025},
  doi = {10.1111/codi.70257}
}
Start for free →